Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 68071-4346 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

68071 4346 9

68071 4346 9

This is a warning label of Gabapentin 800mg tablets shown in the format of Lot and Exp number for the prescription drug. The label also warns to keep the drug out of reach of children and suggests calling a doctor in case of side effects. The controlled temperature for storing the drug is between 59-86°F.*

Figure 1 - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

Figure 1 - ab1e0185 b802 4cf2 a5d4 b71f27f1dcb0 00

This appears to be a formula for calculating creatinine clearance (ClCr) in patients, using their age, weight, and serum creatinine levels. The calculation involves multiplying the patient's age in years by their weight in kilograms and dividing the result by 72 times their serum creatinine level measured in mg/dL. For female patients, the result is then multiplied by 0.85. ClCr is a measure of kidney function and is often used to adjust medication dosages in patients with impaired renal function.*

Chem Structure - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

Chem Structure - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 01

figure01 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

figure01 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 02

figure02 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

figure02 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 03

This appears to be a chart or table, displaying various dosages of gabapentin and a placebo being tested for pain reduction over a 4-week period. The mean pain score is likely measured on a scale of 1-7, with baseline being the initial measurement before any treatment was administered and subsequent measurements taken at the end of each week.*

figure03 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

figure03 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 04

This is a statistical report of a clinical study on PHN that compares the efficacy of GBP (possibly Gabapentin drug) and placebo in reducing the pain score of patients. The report presents a graph (Figure 3) that shows the percentage of patients who responded positively (with more than 50% pain score reduction) at the endpoint of the study. It seems that Study 1 had a higher percentage of responders (around 32%) than Study 2 (around 34%). There are also notes indicating the statistical significance of the results (p < 0.001) and some values of GBP and PBO, possibly representing the cost or dosage of the treatment.*

figure4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

figure4 - d45f499b 8612 479e 8dd2 4fe28b1f5f9c 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.